Kim, J. S., Kim, J. E., Kim, K., Lee, J., Park, J. O., Lim, H. Y., . . . Kim, S. T. (2017). The Impact of Cetuximab Plus AKT- or mTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model with Wild-Type RAS and PIK3CA Mutation. J Cancer.
Citação norma ChicagoKim, Ju Sun, Jung Eun Kim, Kyung Kim, Jeeyun Lee, Joon Oh Park, Ho Yeong Lim, Young Suk Park, Won Ki Kang, and Seung Tae Kim. "The Impact of Cetuximab Plus AKT- or MTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model With Wild-Type RAS and PIK3CA Mutation." J Cancer 2017.
Citação norma MLAKim, Ju Sun, et al. "The Impact of Cetuximab Plus AKT- or MTOR- Inhibitor in a Patient-Derived Colon Cancer Cell Model With Wild-Type RAS and PIK3CA Mutation." J Cancer 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.